Evidence map›Paper›PMID 38790279›Full record

ArticleBioengineering (Basel, Switzerland)2024

Cancerous and Non-Cancerous MRI Classification Using Dual DCNN Approach.

Zubair Saeed, Othmane Bouhali, Jim Xiuquan Ji, Rabih Hammoud, Noora Al-Hammadi, Souha Aouadi, Tarraf Torfeh

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zubair SaeedDepartment of Electrical & Computer Engineering, Texas A&M University, College Station, TX 47080, USA.
Othmane BouhaliDepartment of Electrical & Computer Engineering, Texas A&M University at Qatar, Doha 23874, Qatar.
Jim Xiuquan JiDepartment of Electrical & Computer Engineering, Texas A&M University, College Station, TX 47080, USA.
Rabih HammoudDepartment of Radiation Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0002-5537-3942
Noora Al-HammadiDepartment of Radiation Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0001-5231-0017
Souha AouadiDepartment of Radiation Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0002-9839-2908
Tarraf TorfehDepartment of Radiation Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0002-8758-9481

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain cancer is a life-threatening disease requiring close attention. Early and accurate diagnosis using non-invasive medical imaging is critical for successful treatment and patient survival. However, manual diagnosis by radiologist experts is time-consuming and has limitations in processing large datasets efficiently. Therefore, efficient systems capable of analyzing vast amounts of medical data for early tumor detection are urgently needed. Deep learning (DL) with deep convolutional neural networks (DCNNs) emerges as a promising tool for understanding diseases like brain cancer through medical imaging modalities, especially MRI, which provides detailed soft tissue contrast for visualizing tumors and organs. DL techniques have become more and more popular in current research on brain tumor detection. Unlike traditional machine learning methods requiring manual feature extraction, DL models are adept at handling complex data like MRIs and excel in classification tasks, making them well-suited for medical image analysis applications. This study presents a novel Dual DCNN model that can accurately classify cancerous and non-cancerous MRI samples. Our Dual DCNN model uses two well-performed DL models, i.e., inceptionV3 and denseNet121. Features are extracted from these models by appending a global max pooling layer. The extracted features are then utilized to train the model with the addition of five fully connected layers and finally accurately classify MRI samples as cancerous or non-cancerous. The fully connected layers are retrained to learn the extracted features for better accuracy. The technique achieves 99%, 99%, 98%, and 99% of accuracy, precision, recall, and f1-scores, respectively. Furthermore, this study compares the Dual DCNN's performance against various well-known DL models, including DenseNet121, InceptionV3, ResNet architectures, EfficientNetB2, SqueezeNet, VGG16, AlexNet, and LeNet-5, with different learning rates. This study indicates that our proposed approach outperforms these established models in terms of performance.

Indexed as

alexNetclassificationdeep convolutional neural networksdeep learningdenseNet121dual DCNN modelefficientNetB2inceptionV3learning ratesleNet-5machine learningmagnetic resonance imagingresNet18resNet34resNet50squeezeNetVGG16

Identifiers

PMID38790279
PMCPMC11118162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.